PubMed Health⌕ Search

PubMed · 3843689

Follicular carcinoma.

Abstract

The workshop participants agreed on the following points regarding follicular carcinoma: Follicular carcinoma should be divided into two groups according to its degree of invasion: encapsulated and widely invasive. Patients in the first group only occasionally develop distant metastases, whereas in the second group the prognosis is much poorer. In encapsulated follicular tumors, high cellularity and nuclear atypia should not be used as criteria of malignancy; this diagnosis should be based on the presence of vascular or capsular invasion. Only tumor thrombi occurring in vessels in or outside the capsule should be regarded as indicative of vascular invasion. Capsular invasion should be diagnosed only if penetration of the whole capsule is seen. We agree that some tumor islands within the capsule may represent true tumor invasion, but we believe that some others may be due to capsular infoldings or tangential sectioning. Whenever tumor tissue within the capsule is seen, additional tissue blocks from the capsular area should be processed in a search for capsular penetration or vascular invasion. The degree of differentiation in follicular carcinoma does not correlate to the course of disease as clearly as the degree of invasion, although the so-called insular or poorly differentiated, subtype seems to have a poorer prognosis. Thyroid carcinomas composed of large eosinophilic cells (Hürthle cell carcinomas) usually show follicular differentiation and are therefore included in the category of follicular carcinoma. The same diagnostic criteria of malignancy that apply for other follicular tumors should be used when evaluating these tumors. Although follicular carcinomas often show foci of clear cells, tumors composed solely of clear cells are rare. Most pure clear-cell tumors in the thyroid represent metastatic tumors, usually from the kidney. In the distinction of follicular carcinoma from papillary carcinoma, all differential diagnostic criteria should be used. However, in some cases, the diagnosis can be based on one criterion only, mainly the presence of widespread ground-glass nuclei or abundant neoplastic papillae in papillary carcinoma. The presence of occasional papillae in encapsulated tumors composed of large eosinophilic cells is not sufficient for the diagnosis of papillary carcinoma if the other microscopic features of this tumor are lacking.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K O Franssila, L V Ackerman, C L Brown, C E Hedinger. 1985. Follicular carcinoma.. https://pubmed.ncbi.nlm.nih.gov/3843689/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The case for routine use of adjuvant therapy in pancreatic cancer.

Pancreatic cancer is a devastating disease with a poor prognosis for most patients. Surgical resection remains the cornerstone of treatment, providing the only realistic hope of long-term survival. Even with optimal surgical management, 5-year survival averages 15% to 20% for resectable disease. Progress is being made, however. Currently, the benefits of postoperative therapy for resected pancreatic ductal adenocarcinoma appear clear, and recommendations for such therapy appear to us to be well justified. Additional benefit to patients awaits the development of new agents, molecular targeted drugs, and novel approaches such as immunotherapy.

Adenocarcinoma↗

Proposal for a new definition of true cardia carcinoma.

BACKGROUND AND OBJECTIVES: It remains controversial whether cardia carcinoma should be categorized and treated as esophageal cancer or gastric cancer. The purpose of this study was to develop a reasonable definition of cardia carcinoma. METHODS: Patients with Siewert type II carcinomas were divided into two subgroups: 25 patients with a tumor center within 1 cm of the esophagogastric junction (EGJ) (type IIA) and 22 patients with tumor center 1-2 cm aboral of the EGJ (type IIB). Patients with subcardia carcinomas, 40 with invasion to the EGJ (type III) and 110 without (type IIIe-), were used as controls. RESULTS: The patients with type IIB carcinomas showed no different characteristics from those with type III or type IIIe- carcinomas, except for the stage of the disease. On the other hand, those with type IIA carcinomas were associated with a higher male/female ratio, higher incidences of elevated appearance, differentiated histology, and mediastinal node metastasis, and a significantly lower survival rate as compared with patients with subcardia carcinomas. Multivariate survival analysis revealed that type IIA is a significant prognostic determinant, but that type IIB is not. CONCLUSION: Type IIA carcinomas should be treated as true cardia carcinoma; type IIB as subcardia carcinoma. Our results should be confirmed by a prospective study.

Adenocarcinoma↗

Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer.

BACKGROUND: The prognosis of patients with liver metastasis from gastric cancer (LMGC) is dismal. The purpose of this study was to review our recent outcomes of hepatectomy for LMGC and to determine the suitable candidates for surgery. STUDY DESIGN: The outcomes of 37 patients with LMGC who underwent hepatectomy between 1990 and 2005 were assessed. No extrahepatic distant metastasis and feasibility of macroscopic curative resection were requisite indications for surgery. The prognostic values of clinicopathological factors were assessed by univariate and multivariate analyses. RESULTS: There was no in-hospital mortality. The median survival time and overall 5-year survival rate after hepatectomy of the patients with LMGC were 31 months and 11%, respectively. Intrahepatic recurrence following hepatectomy was found in 23 patients (62%). Variables independently associated with poor survival were bilobar metastasis (P = 0.002, CI = 1.9-16.3) and a maximum tumor diameter of >or= 4 cm (P = 0.006, CI = 1.4-7.7). The depth of the primary tumor and the timing of metastasis were not associated with survival. CONCLUSIONS: Surgical resection for LMGC may be indicated in patients with unilobar metastasis and/or tumors less than 4 cm in diameter. Synchronous metastasis is not a contraindication for hepatectomy.

Adenocarcinoma↗